Literature DB >> 921021

Efficacy of isolated colostral IgA, IgG, and IgM(A) to protect neonatal pigs against the coronavirus of transmissible gastroenteritis.

S S Stone, L J Kemeny, R D Woods, M T Jensen.   

Abstract

To ascertain what class of immunoglobulin (Ig; IgA, IgG, or IgM) is most efficacious in protection, a large quantity of colostrum from sows immunized with virulent transmissible gastroenteritis (TGE) virus was fractionated by chromatographic and gel filtration methods. The isolated IgG, IgA, and IgM(A) had specific virus-neutralizing activities of 1:7.6, 1:342, and 1:302 per milligram of protein, respectively. Each Ig was fed to groups of hysterectomy-derived colostrum-deprived neonatal pigs before and after exposure (challenge) with virulent TGE virus. The 7 pigs fed IgG survived the challenge exposure, but 2 of 7 fed IgA and 1 of 7 fed IgM(A) died of TGE. Three of the survivor pigs that had been fed IgG and 2 of the survivor pigs that had been fed IgA had increased serum antibody titers between 8 and 19 days after challenge exposure, but none of the survivor pigs fed IgM(A) had TGE antibody. In contrast, 12 of 14 virus-control pigs died of TGE and the 2 survivors had antibody conversion. The data show that all 3 Ig classes in immune colostrum will protect neonatal pigs against exposure with virulent TGE virus.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 921021

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  14 in total

1.  Interference of coronavirus infection by expression of immunoglobulin G (IgG) or IgA virus-neutralizing antibodies.

Authors:  J Castilla; I Sola; L Enjuanes
Journal:  J Virol       Date:  1997-07       Impact factor: 5.103

2.  Detection of antirotavirus immunoglobulins A, G, and M in swine colostrum, milk, and feces by enzyme-linked immunosorbent assay.

Authors:  G Corthier; J Franz
Journal:  Infect Immun       Date:  1981-02       Impact factor: 3.441

3.  Lactogenic immunity to transmissible gastroenteritis (TGE) of swine induced by the attenuated Nouzilly strain of TGE virus: passive protection of piglets and detection of serum and milk antibody classes by ELISA.

Authors:  S Bernard; J Shirai; I Lantier; E Bottreau; J M Aynaud
Journal:  Vet Immunol Immunopathol       Date:  1990-01       Impact factor: 2.046

4.  Serum antibody responses of neonatal and young adult pigs to transmissible gastroenteritis coronavirus.

Authors:  S S Stone; L J Kemeny; M T Jensen
Journal:  Vet Immunol Immunopathol       Date:  1982-09       Impact factor: 2.046

5.  Efficacy of antiserum produced in goats and pigs to passively protect piglets against virulent transmissible gastroenteritis virus.

Authors:  R D Woods; R D Wesley
Journal:  Can J Vet Res       Date:  1992-04       Impact factor: 1.310

6.  Engineering passive immunity in transgenic mice secreting virus-neutralizing antibodies in milk.

Authors:  J Castilla; B Pintado; I Sola; J M Sánchez-Morgado; L Enjuanes
Journal:  Nat Biotechnol       Date:  1998-04       Impact factor: 54.908

7.  Characterization of transmissible gastroenteritis coronavirus S protein expression products in avirulent S. typhimurium delta cya delta crp: persistence, stability and immune response in swine.

Authors:  C Smerdou; A Urniza; R Curtis; L Enjuanes
Journal:  Vet Microbiol       Date:  1996-01       Impact factor: 3.293

8.  Immunological activities of milk.

Authors:  T J Newby; C R Stokes; F J Bourne
Journal:  Vet Immunol Immunopathol       Date:  1982-01       Impact factor: 2.046

9.  Increased litter survival rates, reduced clinical illness and better lactogenic immunity against TGEV in gilts that were primed as neonates with porcine respiratory coronavirus (PRCV).

Authors:  Ronald D Wesley; Kelly M Lager
Journal:  Vet Microbiol       Date:  2003-09-01       Impact factor: 3.293

Review 10.  Immunity to transmissible gastroenteritis virus and porcine respiratory coronavirus infections in swine.

Authors:  L J Saif; J L van Cott; T A Brim
Journal:  Vet Immunol Immunopathol       Date:  1994-10       Impact factor: 2.046

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.